Iron Triangle Partners LP Legend Biotech Corp Transaction History

Iron Triangle Partners LP

  • $982 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$57.25 - $69.74 $4.16 Million - $5.07 Million
-72,629 Reduced 16.05%
380,000 $22.9 Million
Q3 2023

Nov 14, 2023
BUY
$63.16 - $76.5 $28.6 Million - $34.6 Million
452,629 New
452,629 $30.4 Million
Q1 2023

May 15, 2023
BUY
$43.42 - $57.37 $21.7 Million - $28.7 Million
500,000 New
500,000 $24.1 Million
Q2 2022

Aug 15, 2022
BUY
$33.54 - $55.0 $16.6 Million - $27.2 Million
495,329 New
495,329 $27.2 Million

Others Institutions Holding LEGN

# of Institutions
212
Shares Held
77.9M
Call Options Held
412K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Iron Triangle Partners LP Portfolio

Follow Iron Triangle Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Triangle Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Iron Triangle Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email